噻吗洛尔滴眼液治疗婴幼儿浅表型血管瘤的meta分析

doi:10.3969/j.issn.1006-5253.2023.03.014

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (2791 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

文章导读

摘要目的对噻吗洛尔滴眼液治疗浅表型婴幼儿血管瘤进行meta分析。方法检索噻吗洛尔滴眼液治疗浅表型婴幼儿血管瘤的随机对照研究（RCTs），筛选文献、提取数据并评价研究质量，使用RevMan 5.3和Stata 11.0软件进行评价。结果纳入7项研究，共706例患者。meta分析结果显示，噻吗洛尔滴眼液治疗婴幼儿浅表型血管瘤的有效率、显效率明显高于对照组（P<0.001），而ADR发生率差异无统计学意义(P=0.570)；年龄≤6个月与＞6个月的婴幼儿相比，控制率差异无统计学差异(P=0.380)，但消退率明显较高(P=0.004)。结论噻吗洛尔滴眼液治疗浅表型婴幼儿血管瘤安全有效，且年龄≤6个月的婴幼儿效果更佳。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	徐锦龙
	叶家兴
	陈武
	马卫成

关键词 ：噻吗洛尔, 婴幼儿, 浅表型血管瘤, meta分析

Abstract：Objective To study the meta-analysis of timolol eye drops in the treatment of superficial hemangioma in infants.Methods Randomized controlled trials (RCTs) of timolol eye drops in the treatment of superficial infantile hemangioma were retrieved. Literature was screened, data were extracted and research quality was evaluated with RevMan 5.3 software and Stata 11.0 software.Results Seven studies involving 706 patients were included. The results of meta-analysis showed that the effective rate and marked efficiency of timolol eye drops in the treatment of superficial hemangioma in infants were significantly higher than those in the control group (P<0.001), while the incidence of ADR was not significantly different (P=0.570). Compared with infants aged less than 6 months and over 6 months, the control rate was not significantly different (P=0.380), but the regression rate was significantly higher (P=0.004).Conclusion Timolol eye drops are safe and effective in the treatment of superficial infantile hemangioma, and the effect is better in infants aged less than 6 months.

Key words： timolol infant superficial hemangioma meta-analysis

收稿日期: 2022-11-28

PACS:

基金资助:浙江省药学会科技计划项目（2018ZYY38）

通讯作者: 徐锦龙，Email：xgaoxiaozi@163.com

引用本文:

徐锦龙，叶家兴，陈武，马卫成. 噻吗洛尔滴眼液治疗婴幼儿浅表型血管瘤的meta分析 [J]. 中国医院统计, 2023, 30(3): 232-235.
Xu Jinlong，Ye Jiaxing，Chen Wu，Ma Weicheng. Meta-analysis of timolol eye drops in the treatment of superficial hemangioma in infants. journal1, 2023, 30(3): 232-235.

链接本文:

http://manu58.magtech.com.cn/Jwk_zgyytj/CN/10.3969/j.issn.1006-5253.2023.03.014 或 http://manu58.magtech.com.cn/Jwk_zgyytj/CN/Y2023/V30/I3/232

［1］KHAN M, BOYCE A, PRIETO-MERINO D, et al. The role of topical timolol in the treatment of infantile hemangiomas: A systematic review and meta-analysis［J］. Acta Derm Venereol, 2017, 97(10):1167-1171. DOI: 10.2340/00015555-2681.
［2］KROWCHUK D P, FRIEDEN I J, MANCINI A J, et al. Clinical practice guideline for the management of infantile hemangiomas［J］. Pediatrics, 2019, 143(1):e20183475. DOI: 10.1542/peds.2018-3475.

［3］L-AUT-LABR?ZE C, DUMAS DE LA ROQUE E, HUBICHE T, et al. Propranolol for severe hemangiomas of infancy［J］. N Engl J Med, 2008, 358(24):2649-2651. DOI: 10.1056/NEJMc0708819.

［4］GUO S Q，NI N N. Topical treatment for capillary hemangioma of the eyelid using β-blocker solution［J］. Arch Ophthalmol, 2010, 128(2):255-256. DOI: 10.1001/archophthalmol.2009.370.

［5］CHAMBERS C B, KATOWITZ W R, KATOWITZ J A, et al. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas［J］. Ophthalmic Plast Reconstr Surg, 2012, 28(2):103-106. DOI: 10.1097/IOP.0b013e31823bfffb.

［6］中华医学会整形外科分会血管瘤和脉管畸形学组．血管瘤和脉管畸形诊断和治疗指南：2016版［J］．组织工程与重建外科杂志，2016，12(2)：63-93．DOI: 10.3969/j.issn.1673-0364.2016.02.001.

［7］WANER M，SUEN J Y．A classification of congenital vascular lesions［M］//WANER M，SUEN J Y．Hemangiomas and vascular malformations of the head and neck．New York：Wiley-Liss，1999:1-12．

［8］ACHAUER B M, CHANG C J, VANDER KAM V M. Management of hemangioma of infancy: Review of 245 patients［J］. Plast Reconstr Surg, 1997, 99(5):1301-1308. DOI: 10.1097/00006534-199704001-00014.

［9］罗春芬，黎胜苗，苏宝利，等．外用噻吗洛尔治疗浅表婴幼儿血管瘤的近期疗效与安全性评价［J］．中华小儿外科杂志，2013，34(4)：241-244．DOI: 10.3760/cma.j.issn.0253-3006.2013.04.001.

［10］YU L J, LI S M, SU B L, et al. Treatment of superficial infantile hemangiomas with timolol: Evaluation of short-term efficacy and safety in infants［J］. Exp Ther Med, 2013, 6(2):388-390. DOI: 10.3892/etm.2013.1176.

［11］陈玉兰．马来酸噻吗洛尔治疗婴幼儿浅表性血管瘤的临床观察［J］．中国医疗美容，2015，5(5)：89-90．DOI: 10.19593/j.issn.2095-0721.2015.05.042.

［12］於林军，许嘉川，苏宝利，等．马来酸噻吗洛尔滴眼液治疗婴幼儿表浅血管瘤的临床研究［J］．中华整形外科杂志，2015，31(6)：440-445．DOI: 10.3760/cma.j.issn.1009-4598.2015.06.011.

［13］王洁，赵菊花．马来酸噻吗洛尔滴眼液对婴幼儿浅表性血管瘤的治疗效果观察［J］．内蒙古医学杂志，2017，49(12)：1422-1424．DOI: 10.16096/J.cnki.nmgyxzz.2017.49.12.005.

［14］虞满明，龚卫平．马来酸噻吗洛尔滴眼液治疗婴幼儿浅表性血管瘤效果观察［J］．中国乡村医药，2017，24(4)：28-29．DOI: 10.19542/j.cnki.1006-5180.000110.

［15］钟秀玲，曹玉忠，陈建文，等．马来酸噻吗洛尔滴眼液治疗儿童浅表型血管瘤的疗效观察［J］．现代诊断与治疗，2018，29(21)：3496-3497．DOI: 10.3969/j.issn.1001-8174.2018.21.057.